A Novel Autoantibody against LAG-3 in Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune tolerance loss, although its pathogenesis remains incompletely understood. Immune checkpoint molecules maintain peripheral tolerance, and their dysregulation contributes to autoimmunity. Autoantibodies against lymphocyte activation gene-3 (LAG-3), an immune checkpoint molecule, were identified in a subset of patients with SLE. We enrolled 130 patients with SLE, 119 patients with other autoimmune diseases, and 32 healthy controls. The sera of patients with SLE were screened for antibodies against various immune checkpoint molecules to identify clinically relevant disease-specific autoantibodies against LAG-3. Functional assays were performed to assess the effect of anti-LAG-3 autoantibodies on the interaction between LAG-3 and major histocompatibility complex (MHC) class II. Pathogenic relevance was evaluated using genetic deletion and immunization-based mouse models. Anti-LAG-3 autoantibodies were detected in 52/130 patients with SLE (40.0%) but only 4 of 119 patients with other autoimmune diseases (3.4%). These autoantibodies were associated with lupus nephritis and higher disease activity. In mice, Lag3 deletion or human LAG-3 immunization induced lupus-like autoimmunity. These findings support the clinical relevance of anti-LAG-3 autoantibodies in SLE and implicate LAG-3 checkpoint disruption in lupus-like autoimmunity.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-20
DOI
https://doi.org/10.64898/2026.11.14.761730
Primary Topic
Systemic Lupus Erythematosus Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

A Novel Autoantibody against LAG-3 in Systemic Lupus Erythematosus

Hiroshi Seno, Masataka Yokode, Yukako Maeda, Takahisa Maruno et al.
bioRxiv (Cold Spring Harbor Laboratory)
Systemic Lupus Erythematosus Research
preprint

A Novel Autoantibody against LAG-3 in Systemic Lupus Erythematosus

Hiroshi Seno, Masataka Yokode, Yukako Maeda, Takahisa Maruno, Yoshihiro Nishikawa, Takafumi Yanaidani, Mao Mizuta, Masahiro Shiokawa, Hajime Yoshifuji, Yuya Muramoto, Sakiko Ota, Keiji Akamine, Tomoaki Matsumori, Ran Nakashima, Takeshi Kuwada, Ayako Hirata, Tatsuaki Tsuruyama, Kazushi Izawa, Akio Morinobu, Junko Takita, Eitaro Hiejima, Koki Chikugo, Kenji Sawada, Hiroyuki Yoshida, Masaaki Fujita, Tsutomu Chiba, Shimpei Matsumoto
preprint en

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune tolerance loss, although its pathogenesis remains incompletely understood. Immune checkpoint molecules maintain peripheral tolerance, and their dysregulation contributes to autoimmunity. Autoantibodies against lymphocyte activation gene-3 (LAG-3), an immune checkpoint molecule, were identified in a subset of patients with SLE. We enrolled 130 patients with SLE, 119 patients with other autoimmune diseases, and 32 healthy controls. The sera of patients with SLE were screened for antibodies against various immune checkpoint molecules to identify clinically relevant disease-specific autoantibodies against LAG-3. Functional assays were performed to assess the effect of anti-LAG-3 autoantibodies on the interaction between LAG-3 and major histocompatibility complex (MHC) class II. Pathogenic relevance was evaluated using genetic deletion and immunization-based mouse models. Anti-LAG-3 autoantibodies were detected in 52/130 patients with SLE (40.0%) but only 4 of 119 patients with other autoimmune diseases (3.4%). These autoantibodies were associated with lupus nephritis and higher disease activity. In mice, Lag3 deletion or human LAG-3 immunization induced lupus-like autoimmunity. These findings support the clinical relevance of anti-LAG-3 autoantibodies in SLE and implicate LAG-3 checkpoint disruption in lupus-like autoimmunity.

bioRxiv (Cold Spring Harbor Laboratory)
Kyoto University (JP), Kyoto Pharmaceutical University (JP), Kansai Electric Power Hospital (JP), Kobe Children's Hospital (JP), Kobe City Medical Center West Hospital (JP), Tokyo Metropolitan Children's Medical Center (JP)
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon